| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verve Therapeutics, Inc. | Chief Medical Officer | Restricted Stock Units | 22,000 | $220,000 | $10.00 | 14 Feb 2024 | Direct |
| Verve Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 90,000 | 14 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics, Inc. | 14 Feb 2024 | 2 | $0 | 4 | Chief Medical Officer | 16 Feb 2024, 16:30 |
| VERV | Verve Therapeutics, Inc. | 18 Sep 2023 | 1 | $0 | 4 | Chief Medical Officer | 19 Sep 2023, 17:05 |
| VERV | Verve Therapeutics, Inc. | 18 Sep 2023 | 0 | $0 | 3 | Chief Medical Officer | 19 Sep 2023, 17:00 |